[ Back to EurekAlert! ]

Contact: Mika Ono
mikaono@scripps.edu
Scripps Research Institute

HIV/AIDS Vaccine Target

Caption: The team funded by the CHAVI-ID grant is working on ways to help the immune system recognize and attack the HIV envelope trimer (shown here), which is masked by sugar molecules known collectively as the “glycan shield” (shown in blue).

Credit: Courtesy of the Burton lab, the Scripps Research Institute

Usage Restrictions: None

Related news release: Scripps Research Institute wins $77 million to develop AIDS vaccine center


[ Back to EurekAlert! ]